Skip to main content

ChAdOx1 nCoV-19


Professor Sarah Gilbert | Vaccine Europe

https://www.drugbank.ca/drugs/DB15656


The Oxford University's Jenner Institute
and the Oxford Vaccine Group began research in January to find a vaccine for Covid-19. More than 800 volunteers were recruited to administer the vaccine they discovered experimentally. Alyssa Granato was one of two people vaccinated on Thursday.

He is also a scientist. He said he took part in the trial to help with science research. Participants are divided into two groups. One group will be vaccinated against Covid-19. The other group is meningitis. Participants will not be told what is being given to whom. They will be monitored.

Professor Sarah Gilbert is leading the research team at Oxford University. "Personally, I am very optimistic about this antidote," he said. Of course we have to test it and collect information about it from people.

We need to make sure that it works and that we can prevent more cases of coronary heart disease by vaccinating more people. " Earlier, Gilbert said he was 80 per cent sure the vaccine would work, according to a BBC report. But now he doesn't want to say that anymore. Now Gilbert says he is "very optimistic" about the vaccine.

The vaccine made by Oxford is called 'ChAdOx1 nCoV-19'. It is made from adenovirus. Adenovirus is a common cold-fever virus that originates from chimpanzees. The virus has been used as a vector. The vector vaccine is a type of vaccine that allows the nucleic acid of a harmful virus to enter the human body through a carrier bacterium.

The carrier germs are good, they do no harm. Once in the body, they make some essential proteins (spike proteins) with the help of the nucleic acids of the bad virus. The human body then begins to make antibodies to block proteins. Before the disease occurs, the body develops immunity to the disease. Scientists at Oxford claim that the method is safe for children, the elderly and even the sick.

Comments

Popular posts from this blog

Swami Vivekananda’s speech on 11th September, 1893 in Chicago

to listen his video of original voice click here Sisters and Brothers of America , It fills my heart with joy unspeakable to rise in response to the warm and cordial welcome which you have given us. I thank you in the name of the most ancient order of monks in the world; I thank you in the name of the mother of religions, and I thank you in the name of millions and millions of Hindu people of all classes and sects. My thanks, also, to some of the speakers on this platform who, referring to the delegates from the Orient, have told you that these men from far-off nations may well claim the  honor  of bearing to different lands the idea of toleration. I am proud to belong to a religion which has taught the world both tolerance and universal acceptance. We believe not only in universal toleration, but we accept all religions as true. I am proud to belong to a nation which has sheltered the persecuted and the refugees of all religions and all nations of the earth. I am ...

India’s 1st COVID-19 vaccine gets human trial approval

NEW DELHI, India India’s first COVID-19 vaccine got the approval for human trials from the country’s drug regulator, as number of coronavirus-related cases and deaths continues upward, a drug company announced. The vaccine, named COVAXIN, has been developed by Bharat Biotech compnay , in collaboration with the Indian Council of Medical Research and the National Institute of Virology (NIV). The indigenous, inactivated vaccine was developed from a SARS-CoV-2 strain, which was isolated by the NIV and transferred to the company’s BSL-3 High Containment facility located at Hyderabad city in southern India, Bharat Biotech said in a statement. “Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic, ” said Suchitra Ella, joint managing director of the company. The permission to initiate Phase I & II Human clinical trials came after the company submitted results generated from preclinica...

ISRO Chief K Sivan named for Von Karman Award 2020

Indian Space Research Organisation(ISRO) Chief,  Kailasavadivoo Sivan  has named for  Von Karman Award   2020  by the  International Academy of Astronautics (IAA) . The Von Karman Award is known as the highest distinction of the IAA. Dr K. Sivan is going to receive an award in March 2021 at Paris France. Prof.  Udupi Ramachandra Rao  was the first Indian to receive the von Karman award. The award was presented to him in  2005  and Dr  Krishnaswamy Kasturirangan  received the Von Karman award in  2007. Boost your Banking Awareness Knowledge with Adda247 Live Batch:  WARRIOR 2.0 | Banking Awareness Batch for SBI, RRB, RBI and IBPS Exams About von Karman Award: Important takeaways for all competitive exams: source: https://m.dailyhunt.in/news/india/english/adda247-epaper-adda/isro+chief+k+sivan+named+for+von+karman+award+2020-newsid-n198554864